Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,370.00
-12.00 (-0.50%)
Oct 14, 2026, 1:34 PM IDT
Kamada Employees
Kamada had 462 employees as of December 31, 2025. The number of employees increased by 42 or 10.00% compared to the previous year. That makes Kamada the 20,676th largest employer in the world and 148th in Israel.
Employees
462
Change (1Y)
42
Growth (1Y)
10.00%
Revenue / Employee
1.24M ILS
Profits / Employee
143.49K ILS
Market Cap
1.37B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 462 | 42 | 10.00% |
| Dec 31, 2024 | 420 | 42 | 11.11% |
| Dec 31, 2023 | 378 | -2 | -0.53% |
| Dec 31, 2022 | 380 | 25 | 7.04% |
| Dec 31, 2021 | 355 | -53 | -12.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Amal Holdings A.D. | 30,248 |
| Danel (Adir Yeoshua) | 4,288 |
| Novolog (Pharm-Up 1966) | 916 |
| InterCure | 285 |
| Rafa Laboratories | 257 |
| Bait Bakfar | 244 |
| Ilex Medical | 181 |
| SofWave Medical | 151 |
Kamada News
- 7 days ago - Kamada launches two new biosimilar products in Israel - TheFly
- 8 days ago - Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel - GlobeNewsWire
- 16 days ago - Kamada (NASDAQ:KMDA) -- Growth Potential in Biopharmaceuticals | Renaissance Investment ... - GuruFocus
- 16 days ago - Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - MarketBeat
- 19 days ago - Kamada Transcript: Small-Cap Virtual Conference - Transcripts
- 26 days ago - Kamada Ltd (KMDA) Director David Tsur Sells 22,827 Shares - GuruFocus
- 26 days ago - Kamada Confirms KedRAB Supply As U.S. Rabies Exposures Increase - Nasdaq
- 26 days ago - Kamada confirms sufficient KedRAB supply amid increased demand - TheFly